2026 Summer Intern - Antibody Engineering jobs in United States
cer-icon
Apply on Employer Site
company-logo

Roche · 4 hours ago

2026 Summer Intern - Antibody Engineering

Roche is a leading company in the biotechnology industry, and they are seeking a Summer Intern in Antibody Engineering. The role involves driving experiments to advance new antibody-based technologies, characterizing biochemical properties of antibodies, and presenting results to colleagues.

BiotechnologyHealth CareHealth DiagnosticsOncologyPharmaceuticalPrecision Medicine
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Drive experiments aimed at advancing new antibody-based technologies
Characterize biochemical properties of antibodies
Test their activities in functional assay
Present the results of the effort to colleagues in the department

Qualification

Antibody engineeringBiochemical characterizationCell cultureBiacore analysisCommunication skillsCollaboration skillsInterpersonal skills

Required

Must be pursuing a Master's Degree (enrolled student)
Must be pursuing a PhD (enrolled student)
Required Majors: Protein Sciences, Biochemistry, Pharmaceutical Sciences or related field

Preferred

Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Experience with Cell culture, Antibody engineering/characterization and Biacore analysis

Benefits

Paid holiday time off benefits

Company

Roche is a pharmaceutical and diagnostics company that offers medicines and diagnostic tests for various medical conditions and diseases.

H1B Sponsorship

Roche has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (9)
2023 (6)
2022 (2)
2021 (2)

Funding

Current Stage
Public Company
Total Funding
$7.79B
Key Investors
SoftBankSCALE AINovartis
2021-08-04Post Ipo Equity· $5B
2020-12-07IPO
2020-05-06Post Ipo Equity· $0.5M

Leadership Team

leader-logo
Alan Hippe
Member of the Executive Board - Group CFO
linkedin
leader-logo
Christine Bakan
Global Head and VP of Software and Bioinformatics, Next Generation Sequencing
linkedin
Company data provided by crunchbase